A patient with sporadic Creutzfeldt-Jakob disease, a rare brain illness caused by an infectious prion, will receive an investigative treatment called PRN100, an antibody developed by researchers at University College London. "As this is the first time this treatment has been used in humans, we cannot predict what the outcome will be, but laboratory testing has shown the potential to treat prion infection," said Dr. John Collinge.
Treatment for sporadic Creutzfeldt-Jakob disease to be tested in UK
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.